GENB
Generate Biomedicines, Inc.
NASDAQ · Financial Services · Asset Management · US
$17.14
+0.12%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.51
- Revenue estimate
- $7.8M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.52
- EPS estimate
- -$0.51
- Revenue actual
- $6.3M
- Revenue estimate
- $5.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -70.0%
- Revenue beats (12Q)
- 2
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.51 | -$0.52 | Miss -2.30% | $6.3M |
| May 7, 2026 | -$0.45 | -$1.07 | Miss -137.78% | $7.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026